{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:10:11Z","timestamp":1776319811490,"version":"3.50.1"},"reference-count":44,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,5,15]]},"DOI":"10.2169\/internalmedicine.8796-17","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T22:15:30Z","timestamp":1515622530000},"page":"1361-1369","source":"Crossref","is-referenced-by-count":18,"title":["Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm"],"prefix":"10.2169","volume":"57","author":[{"given":"Shozo","family":"Sueda","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ehime Prefectural Niihama Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tsukazaki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Modi S, Krahn AD. Sudden cardiac arrest without overt heart disease. Circulation 123: 2994-3008, 2011.","DOI":"10.1161\/CIRCULATIONAHA.110.981381"},{"key":"2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.66.3.588","volume":"66","author":"DD Miller","year":"1982","unstructured":"2. Miller DD, Waters DD, Szlachcic J, Theroux P. Clinical characteristics associated with sudden death in patients with variant angina. Circulation 66: 588-592, 1982.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bott-Silverman C, Heupler FA. Natural history of pure coronary artery spasm in patients treated medically. J Am Coll Cardiol 2: 200-205, 1983.","DOI":"10.1016\/S0735-1097(83)80154-5"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 75: 1110-1116, 1987.","DOI":"10.1161\/01.CIR.75.6.1110"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 78: 1-9, 1988.","DOI":"10.1161\/01.CIR.78.1.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Myerburg RJ, Kessler KM, Mallon SM, et al. Life-threatening ventricular arrhythmia in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med 326: 1451-1455, 1992.","DOI":"10.1056\/NEJM199205283262202"},{"key":"7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.88.3.1083","volume":"88","author":"AC Powell","year":"1993","unstructured":"7. Powell AC, Fuchs T, Finkelstein DM, et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of -hospital cardiac arrest. Circulation 88: 1083-1092, 1993.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H. Clinical implications of an implantable cardioveter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol 60: 908-913, 2012.","DOI":"10.1016\/j.jacc.2012.03.070"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mitchell LB. Use of the implantable cardioverter-defibrillator in patients with coronary artery spasm as the apparent cause of spontaneous life-threatening ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 60: 914-916, 2012.","DOI":"10.1016\/j.jacc.2012.05.013"},{"key":"10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/europace\/eun292","volume":"10","author":"ML Hendriks","year":"2008","unstructured":"10. Hendriks ML, Allaart CP, Bronzwaer JGF, Res JJC, Cock CC. Recurrent ventricular fibrillation caused by coronary artery spasm leading to implantable cardioverter defibrillatior implantation. Europace 10: 1456-1457, 2008.","journal-title":"EP Europace","ISSN":"https:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Meisel SR, Mazur A, Chetboun I, et al. Usefulness of implantable cardioverter-defibrillator in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. Am J Cardiol 89: 1114-1116, 2002.","DOI":"10.1016\/S0002-9149(02)02283-X"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lacroix D, Kacet S, Lekiefffre J. Vasospastic angina without flow-limiting coronary lesions as a cause for aborted sudden death. Int J Cardiol 43: 247-249, 1994.","DOI":"10.1016\/0167-5273(94)90204-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fuertes J, Gallego P, Peinado R, Merino JL. Implantable cardioverter as therapeutic option for sudden death secondary to severe coronary vasospasm. Int J Cardiol 63: 181-183, 1998.","DOI":"10.1016\/S0167-5273(97)00275-1"},{"key":"14","unstructured":"14. Cheng TO. Implantable cardioverter defibrillator for sudden cardiac death secondary to coronary artery spasm. Int J Cardiol 65: 209-210, 1998."},{"key":"15","unstructured":"15. Fiocca L, Biasi MD, Bruno N, et al. Coronary vasospasm and aborted sudden death treated with an implantable defibrillator and stenting. Ital Heart J 3: 270-273, 2002."},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Postorino C, Gallagher MM, Santini L, et al. Coronary spasm: a case of transient ST elevation and syncopal ventricular tachycardia without angina. Europace 9: 568-570, 2007.","DOI":"10.1093\/europace\/eum087"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Al-Sayegh A, Shukkur AM, Akbar M. Automatic implantable cardioverter defibrillator for the treatment of ventricular fibrillation following coronary artery spasm: a case report. Angiology 58: 122-127, 2007.","DOI":"10.1177\/0003319706295510"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Letsas KP, Filippatos GS, Efremidis M, Sideris A, Kardaras F. Secondary prevention of sudden cardiac death in coronary artery spasm: Is implantable cardioverter defibrillator always efficient? Int J Cardiol 117: 141-143, 2007.","DOI":"10.1016\/j.ijcard.2006.06.055"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mascioli G, Bontempi L, Racheli M, Cerini M, Curnis A, Cas LD. Coronary artery spasm as a cause of ST elevation and inappropriate implantable cardioverter defibrillator intervention. J Cardiovasc Med 8: 1055-1057, 2007.","DOI":"10.2459\/JCM.0b013e328058ed8c"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Walhout RJ, Winter RJ, Simmers TA, Buijs EM. Aborted sudden death in a 52-year-old man without structural heart disease. Neth Heart J 16: 239-241, 2008.","DOI":"10.1007\/BF03086153"},{"key":"21","unstructured":"21. Lee CH, Seow SC, Lim YT. Lethal presentations of coronary artery spasm after an event-free period of six years following initial diagnosis. J Invasive Cardiol 20: E30-E32, 2008."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sovari AA, Cesario D, Kocheril AG, Brugada R. Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm. J Interv Card Electrophysiol 21: 223-226, 2008.","DOI":"10.1007\/s10840-008-9207-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bhat PK, Quan KJ. Implantable cardioverter defibrillator (ICD) for polymorphic ventricular tachycardia (VT) due to coronary vasospasm. J Hosp Med 4: E23-E25, 2009.","DOI":"10.1002\/jhm.482"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Takagi Y, Yasuda S, Takahashi J, et al. Importance of dual induction tests for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest. Circ J 73: 767-769, 2009.","DOI":"10.1253\/circj.CJ-09-0061"},{"key":"25","unstructured":"25. Yildirim AB, Basaric I, Kucuk M. Recurrent ventricular arrhythmias and myocardial infarctions associated with cocaine induced reversible coronary vasospasm. Cardiol J 17: 512-517, 2010."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Takagi Y, Yasuda S, Tsunoda R, et al. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest. Circ J Arrhythm Electrophysiol 4: 295-302, 2011.","DOI":"10.1161\/CIRCEP.110.959809"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ishihara A, Tanaka T, Otsu Y, et al. Prognosis of patients with coronary vasospasm after successful resuscitation from ventricular fibrillation. J Arrhythm 28: 105-110, 2012.","DOI":"10.1016\/j.joa.2012.03.007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nishida J, Kawaukai M, Mochizuki A, et al. Prognosis of vasospastic angina patients who survived cardiac arrest: dose implantable cardioverter-defibrilators have an impact? J Am Coll Cardiol 59(Suppl): E1484, 2012.","DOI":"10.1016\/S0735-1097(12)61485-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hiki M, Tokano T, Nakazato Y, Daida H. Recurrent ventricular fibrillation under sufficient medical treatment with coronary artery spasm. BMJ Case Rep 2013: 2013.","DOI":"10.1136\/bcr-2012-007583"},{"key":"30","unstructured":"30. Mullertz KM, Hansen HS. Cardiac arrest caused by coronary arterial vasospasm. Uqeskr Laeger 174: 1676-1677, 2012."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kawasaki Y, Kato T, Minamino E, Inoko M. Syncope caused by coronary artery spasm without chest pain leading to ventricular fibrillation. BMJ Case Rep 2013: 2013.","DOI":"10.1136\/bcr-2013-010210"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Eschalier R, Souteyrand G, Jean F, et al. Should an implanted defibrillator be considered in patients with vasospastic angina? Arch Cardiovasc Dis 107: 42-47, 2014.","DOI":"10.1016\/j.acvd.2013.10.006"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Eschalier R, Motreff P, Bordachar P. Risk of recurrence after life threatening ventricular arrhythmias in coronary spasm. Arch Cardivasc Dis 107: 205-206, 2014.","DOI":"10.1016\/j.acvd.2014.02.003"},{"key":"34","unstructured":"34. Mousa TM, Akinseye OA, Goldbarg SE. Severe coronary artery spasm and sudden cardiac death : Is there a consensus for management? J Innov Cardiac Rhythm Manag 5: 1657-1660, 2014."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yamashina Y, Yagi T, Namekawa A, et al. Favorable outcomes of patients with vasospastic angina associated with cardiac arrest. J Cardiol 63: 41-45, 2014.","DOI":"10.1016\/j.jjcc.2013.06.011"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gullsen K, Ayca B, Cerit L, Okuyan E. Coronary vasospasm-induced periodic ventricular fibrillation and successful ablation through coronary stenting. Postepy Kardiol Interwencyjnej (Adv Interventional Cardiol) 42: 337-340, 2015.","DOI":"10.5114\/pwki.2015.55608"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Goto K, Kurabayashi M, Nakamura T, et al. Aborted sudden cardiac deathe due to intractable ventricular fibrillation caused by coronary spasm refractory to implantable cardioverter defibrillator therapy. Int J Cardiol 176: e133-e134, 2014.","DOI":"10.1016\/j.ijcard.2014.07.209"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ahn JM, Lee KH, Yoo SY, et al. Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol 68: 137-145, 2016.","DOI":"10.1016\/j.jacc.2016.04.050"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. JCS joint working group. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary spastic angina) (JCS 2013). Circ J 78: 2779-2801, 2014.","DOI":"10.1253\/circj.CJ-66-0098"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34: 2949-3003, 2013. Erratum in: Eur Heart J <b>35<\/b>: 2260-2261, 2014.","DOI":"10.1093\/eurheartj\/eht296"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF\/AHA focused update incorporated into the ACCF\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation <b>127<\/b>: e663-e828, 2013. Erratum in: Circulation <b>127<\/b>: e863-e864, 2013.","DOI":"10.1161\/CIR.0b013e31828478ac"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Sueda S, Kohno H. Overview of the complications during the pharmacological spasm provocation tests. J Cardiol 68: 1-6, 2016.","DOI":"10.1016\/j.jjcc.2016.03.005"},{"key":"43","unstructured":"43. JCS joint working group. Guidelines for non-pharmacotherapy of cardiac arrhythmia (JCS 2011). [Internet]. [cited 2017 May 8]. Available from: http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2011_okumura_h.pdf"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Sueda S, Kohno H, Miyoshi T, Sasaki Y, Sakaue T, Habara H. Spasm provocation tests performed under medical therapy: a new approach for treating patients with refractory coronary spastic angina on emergency admission. Intern Med 53: 1739-1747, 2014.","DOI":"10.2169\/internalmedicine.53.2429"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/10\/57_8796-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T06:50:49Z","timestamp":1570603849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/10\/57_8796-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8796-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]}}}